These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 15111770)

  • 21. Polymorphisms of catechol-O-methyltransferase in men with renal cell cancer.
    Tanaka Y; Hirata H; Chen Z; Kikuno N; Kawamoto K; Majid S; Tokizane T; Urakami S; Shiina H; Nakajima K; Dhir R; Dahiya R
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):92-7. PubMed ID: 17220335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
    Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
    Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms related to estrogen and xenobiotic metabolism in healthy Turkish women.
    Kocabaş NA; Sardaş S; Karakaya AE
    Arch Med Res; 2005; 36(1):19-23. PubMed ID: 15777990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
    Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
    Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria.
    Lajin B; Hamzeh AR; Ghabreau L; Mohamed A; Al Moustafa AE; Alachkar A
    Breast Cancer; 2013 Jan; 20(1):62-6. PubMed ID: 22124994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
    Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms in estrogen-metabolizing genes and breast cancer survival.
    Long JR; Cai Q; Shu XO; Cai H; Gao YT; Zheng W
    Pharmacogenet Genomics; 2007 May; 17(5):331-8. PubMed ID: 17429315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer].
    Zhao XM; Xie MQ; Yang DZ; Wang LA; Li SJ; Zhuang YY; Tang XL
    Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):116-9. PubMed ID: 17442187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.
    Justenhoven C; Pierl CB; Haas S; Fischer HP; Baisch C; Hamann U; Harth V; Pesch B; Brüning T; Vollmert C; Illig T; Dippon J; Ko YD; Brauch H
    Breast Cancer Res Treat; 2008 Sep; 111(1):171-7. PubMed ID: 17922187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.
    Cussenot O; Azzouzi AR; Nicolaiew N; Fromont G; Mangin P; Cormier L; Fournier G; Valeri A; Larre S; Thibault F; Giordanella JP; Pouchard M; Zheng Y; Hamdy FC; Cox A; Cancel-Tassin G
    J Clin Oncol; 2007 Aug; 25(24):3596-602. PubMed ID: 17704407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevalence of Val158Met polymorphism in COMT gene on non-BRCA1/2 hereditary breast cancer].
    Song CG; Hu Z; Yuan WT; Di GH; Shen ZZ; Huang W; Shao ZM
    Zhonghua Wai Ke Za Zhi; 2006 Oct; 44(19):1310-3. PubMed ID: 17217814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
    Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.
    Nock NL; Cicek MS; Li L; Liu X; Rybicki BA; Moreira A; Plummer SJ; Casey G; Witte JS
    Carcinogenesis; 2006 Sep; 27(9):1842-8. PubMed ID: 16569655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of CYP1B1 codon 432 mutant allele in head and neck squamous cell cancer is reflected by somatic mutations of p53 in tumor tissue.
    Ko Y; Abel J; Harth V; Bröde P; Antony C; Donat S; Fischer HP; Ortiz-Pallardo ME; Thier R; Sachinidis A; Vetter H; Bolt HM; Herberhold C; Brüning T
    Cancer Res; 2001 Jun; 61(11):4398-404. PubMed ID: 11389067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Jan; 119(2):463-74. PubMed ID: 19424794
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estrogens metabolism associated with polymorphisms: influence of COMT G482a genotype on age at onset of canine mammary tumors.
    Dias Pereira P; Lopes CC; Matos AJ; Pinto D; Gärtner F; Lopes C; Medeiros R
    Vet Pathol; 2008 Mar; 45(2):124-30. PubMed ID: 18424824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in 2-hydroxyestrone and 16alpha-hydroxyestrone metabolism with flaxseed consumption: modification by COMT and CYP1B1 genotype.
    McCann SE; Wactawski-Wende J; Kufel K; Olson J; Ovando B; Kadlubar SN; Davis W; Carter L; Muti P; Shields PG; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2007 Feb; 16(2):256-62. PubMed ID: 17301257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.
    Singh S; Chakravarti D; Edney JA; Hollins RR; Johnson PJ; West WW; Higginbotham SM; Cavalieri EL; Rogan EG
    Oncol Rep; 2005 Oct; 14(4):1091-6. PubMed ID: 16142378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relation between single nucleotide polymorphism in estrogen-metabolizing genes COMT, CYP17 and breast cancer risk among Chinese women].
    Tan W; Qi J; Xing DY; Miao XP; Pan KF; Zhang L; Lin DX
    Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):453-6. PubMed ID: 14575568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.